73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
29.05. - 01.06.2022, Köln
Vorträge Mittwoch, 01.06.2022
Meningeome – Grundlagen/Meningiomas – basics
Meeting Abstract
(V303)
[Full Text]
AKT1E17K and NF2mutations are the main driver events in spinal meningiomas and are associated with distinct tumour features
Alkhatib M, Hua L, Podlesek D, Günther L, Gong Y, Kirsch M, Schackert G, Juratli T[Full Text]
Meeting Abstract
(V304)
[Full Text]
Standardised generation of tumour-organoids as novel drug screening platform in meningioma
Jungwirth G, Cao J, Warta R, Abdollahi A, Unterberg AW, Herold-Mende C[Full Text]
Meeting Abstract
(V306)
[Full Text]
Sporadic multiple meningiomas harbor distinct driver mutations
Prilop I, Saalfeld FC, Meinhardt M, Wenzel C, Herold S, Zeugner S, Aust DE, Schackert G, Pinzer T, Juratli T[Full Text]
Meeting Abstract
(V307)
[Full Text]
Proliferative potential and the inflammatory tumour microenvironment in meningioma correlate with neurological function at presentation, and anatomical location – from convexity to skull base and spine
Wach J, Lampmann T, Güresir Á, Vatter H, Herrlinger U, Becker A, Hölzel M, Toma M, Güresir E[Full Text]
Meeting Abstract
(V308)
[Full Text]
Combinatorial drug screening identifies synergistic interactions of Bcl-2 inhibitor Navitoclax with MELK inhibitor OTSSP167 and HDAC inhibitor Panobinostat for the treatment of aggressive meningiomas
Cao J, Jungwirth G, Warta R, Unterberg AW, Herold-Mende C[Full Text]
